The Latest Breaking News on Pharma

Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget and issued a light sales view.

Rhythm Pharmaceuticals is near a buy point after strong sales in the second quarter.

The NHS was forced to spend over £80m a year on hydrocortisone tablets after the price was rigged

Travere Therapeutics stock surged Friday after the biotech company snagged full FDA approval for its kidney disease treatment, Filspari.

The peak body for GPs has hit out at a NSW government plan to let pharmacies treat more health conditions to take pressure off doctors.

The healthcare sector is set for robust growth, driven by surging demand for quality treatments, a growing patient base, breakthroughs in biopharma, and supportive policies. Therefore, investors could consider undervalued pharmaceutical stocks like Merck & Co. (MRK), Pfizer (PFE), and Cigna (CI) with significant upside potential. Read more.

Nearly five years after COVID-19, a new analysis by The Associated Press shows that U.S. regulators are struggling to address a massive backlog of uninspected pharmaceutical plants

U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19

Weight-loss drug kingpins Eli Lilly and Novo Nordisk could join the trillion-dollar company club before even Tesla, according to a report.

Dyne Therapeutics stock crashed Tuesday after several key executives departed on the heels of what the company calls "unprecedented" in DMD.

Pinellas Suncoast Transit Authority in Florida takes proactive steps to address opioid crisis by training employees and installing Narcan kits at terminals.